Smith & Nephew PLC
LSE:SN
Smith & Nephew PLC
Cost of Revenue
Smith & Nephew PLC
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Smith & Nephew PLC
LSE:SN
|
Cost of Revenue
-$1.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Cost of Revenue
-$381.9m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Cost of Revenue
-£26.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
Angle PLC
LSE:AGL
|
Cost of Revenue
-£626k
|
CAGR 3-Years
-51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Cost of Revenue
-£15.3m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-448%
|
CAGR 10-Years
N/A
|
|
|
Inspiration Healthcare Group PLC
LSE:IHC
|
Cost of Revenue
-£18.9m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-34%
|
|
Smith & Nephew PLC
Glance View
Smith & Nephew PLC, a name synonymous with innovation in the medical technology sphere, began its journey in the late 19th century in the quaint city of Kingston upon Hull, England. This humble pharmaceutical shop evolved over time into a global leader in medical devices, driven by a commitment to improve people's quality of life through pioneering healthcare solutions. Today, the company stands as a key player in three core sectors: orthopedics, advanced wound management, and sports medicine. By focusing on these specialized areas, Smith & Nephew has set itself apart, effectively addressing the complex challenges faced by aging populations and a rising demand for minimally invasive treatments. Revenue streams pour in from their innovative products, which cater to both healthcare professionals and patients worldwide. In orthopedics, they make significant headway with implants and instruments used in hip and knee replacements, essential solutions in addressing joint deterioration and injury. Their advanced wound management division tackles issues from chronic wounds to burns, supplying dressings and delivery systems designed for optimal healing. Meanwhile, the sports medicine segment contributes by offering arthroscopy and enabling technologies, crucial for athletic injury prevention and recovery. By maintaining a strong pipeline of research and development initiatives, Smith & Nephew continues to enhance its offerings, pushing the envelope in medical technology and consequently fortifying its financial foundation.
See Also
What is Smith & Nephew PLC's Cost of Revenue?
Cost of Revenue
-1.7B
USD
Based on the financial report for Dec 31, 2024, Smith & Nephew PLC's Cost of Revenue amounts to -1.7B USD.
What is Smith & Nephew PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-5%
Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Smith & Nephew PLC have been -5% over the past three years , -5% over the past five years .
You don't have any saved screeners yet